USFDA approves Carvykti for patients with Relapsed or Refractory Multiple Myeloma who have received at least one prior line of therapy Ruchika Sharma7 April 2024 10:00 AM ISTHorsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved CARVYKTI (ciltacabtagene...
USFDA grants Fast Track designation to JnJ nipocalimab to reduce fetal neonatal alloimmune thrombocytopenia risk in alloimmunized pregnant adults Ruchika Sharma27 March 2024 12:30 PM ISTSpring House: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation (FTD) for...
JnJ gets USFDA nod for Opsynvi for chronic treatment of adults with pulmonary arterial hypertension Ruchika Sharma23 March 2024 12:23 PM ISTRaritan: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved OPSYNVI - a single-tablet combination...
USFDA nod to Johnson and Johnson EDURANT PED for certain pediatric patients living with HIV-1 Ruchika Sharma20 March 2024 12:30 PM ISTTitusville: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved EDURANT PED (rilpivirine) for the...
Johnson & Johnson seeks USFDA nod for Tremfya for ulcerative colitis treatment in adults Ruchika Sharma12 March 2024 12:39 PM ISTSpring House: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
Latest JnJ talc trial ends with hung jury Ruchika Sharma8 March 2024 1:30 PM ISTNew York: The latest trial over claims that Johnson & Johnson's talc products cause cancer ended in a mistrial on Tuesday, as a Florida state...
USFDA nod to JnJ for Rybrevant, Chemotherapy combo for lung cancer treatment Anshika Mishra4 March 2024 5:09 PM ISTJohnson & Johnson has announced that following a priority review, the U.S. Food and Drug Administration (FDA) has approved RYBREVANT...
Health Bulletin 04/ March/ 2024 Anshika Mishra4 March 2024 4:44 PM ISTHere the top health news for the day :Lady hardinge medical college to introduce new DNB and FNB courses soon Bringing good news to the postgraduate...
Johnson and Johnson gets USFDA approval for Rybrevant, chemotherapy combo for lung cancer treatment Ruchika Sharma2 March 2024 2:33 PM ISTRaritan: Johnson & Johnson has announced that following a priority review, the U.S. Food and Drug Administration (FDA) has approved RYBREVANT...
JnJ gets USFDA nod for Bi-weekly dose of blood cancer therapy Tecvayli Ruchika Sharma21 Feb 2024 11:39 AM ISTUnited States: The U.S. Food and Drug Administration has approved a bi-weekly dose of Johnson & Johnson's blood cancer therapy Tecvayli, the...
USFDA grants Breakthrough Therapy Designation for JnJ Nipocalimab for individuals at high risk for severe hemolytic disease of fetus, newborn Ruchika Sharma10 Feb 2024 12:06 PM ISTSpring House: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation...
JnJ Balversa gets full USFDA nod to treat locally advanced or metastatic Bladder Cancer with Select Genetic Alterations Ruchika Sharma21 Jan 2024 4:30 PM ISTRaritan: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application...
